EyePoint Pharmaceuticals Inc (EYPT)
19.74
-0.20
(-1.00%)
USD |
NASDAQ |
May 03, 16:00
19.73
-0.01
(-0.05%)
After-Hours: 20:00
EyePoint Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 34.66M |
December 31, 2022 | 39.78M |
September 30, 2022 | 39.73M |
June 30, 2022 | 39.66M |
March 31, 2022 | 39.58M |
December 31, 2021 | 36.56M |
September 30, 2021 | 36.40M |
June 30, 2021 | 36.24M |
March 31, 2021 | 38.12M |
December 31, 2020 | 37.98M |
September 30, 2020 | 50.78M |
June 30, 2020 | 50.26M |
March 31, 2020 | 47.72M |
December 31, 2019 | 47.22M |
September 30, 2019 | 46.73M |
June 30, 2019 | 46.25M |
March 31, 2019 | 31.95M |
September 30, 2018 | 17.46M |
June 30, 2018 | 17.31M |
March 31, 2018 | 12.85M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2023
50.78M
Maximum
Sep 2020
35.14M
Average
39.58M
Median
Mar 2022
Total Long Term Debt (Quarterly) Benchmarks
INVO Bioscience Inc | 2.764M |
Bio-Path Holdings Inc | -- |
Ocular Therapeutix Inc | 74.92M |
Aileron Therapeutics Inc | -- |
Apellis Pharmaceuticals Inc | 93.03M |